Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
Millennium Oncology India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: -Written informed consent. -Consent to undergo PET/CT examination in specific study centers in case of a positive index test result of a healthy subject. -Healthy controls: Age 30-75 years. -Sick population: Histopathology/Cytology proven diagnosis.
Exclusion criteria
Exclusion criteria: -Tumor-related treatment in last 3 months (i.e. Chemotherapy, Radiotherapy, Immunotherapy, Hormone therapy treatment, Surgery etc.) -History of taking any of the following drugs in last 08 week: i. Corticosteroid containing drugs ii. Immunosuppressants (Methotrexate, Cyclosporine, Azathioprine, Tacrolimus, Mycophenolate, Rapamycin, Sirolimus, Adalimumab, Infliximab etc.) : iii. GMCSF (Sargramostim) -History of severe febrile illness or inflammation during the last 8 weeks before blood draw -History of Covid during the last 8 weeks -History of any vaccination during preceding 4 weeks -History of any surgery or severe trauma during last 8 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of recently diagnosed confirmed cancer cases and screening of healthy volunteers by PanTum test kit.Timepoint: 1 month and 2 month | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactCol Harjit Singh Bhagat
Millennium Oncology India Private Limited
Outcome results
None listed